Clinical Trials Sponsored by HIBIOCY CO., Ltd.

Total 10331 results

Genoss Co., Ltd.

Recruiting

Safety and Effectiveness of GENOSS DES in Patients With Multivessel Coronary Artery Disease (GENOSS-MV)

Percutaneous Coronary Intervention | Multivessel Coronary Artery Disease

Korea, Republic of
TCI Co., Ltd.

Recruiting

Efficacy Evaluation of TCI153 Probiotics for Skin Beautification

Skin Condition

Taiwan
Anterogen Co., Ltd.

Recruiting

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical Trial

Diabetic Foot Ulcer

Korea, Republic of
RemeGen Co., Ltd.

Not yet recruiting

Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms

China
HTA Co., Ltd.

Recruiting

Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer

Prostate Cancer

China
RemeGen Co., Ltd.

Recruiting

RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects

NMIBC

China
Curacle Co., Ltd.

Not yet recruiting

Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis (UC)

Ulcerative Colitis
RemeGen Co., Ltd.

Recruiting

A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

Melanoma | Renal Cell Carcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Colorectal Carcinoma

Australia, China
RemeGen Co., Ltd.

Recruiting

A Study of Telitacicept in Patients With Primary IgA Nephropathy

IgA Nephropathy

China
Mezoo Co., Ltd.

Recruiting

Validation of ECG Waveform and Arrhythmia Diagnosis Concordance Using ECG Monitoring Patch and Holter Monitoring

Arrhythmias, Cardiac

Korea, Republic of
RemeGen Co., Ltd.

Recruiting

Efficacy and Safety of RC28-E Versus Aflibercept

Wet Age-related Macular Degeneration

China
RemeGen Co., Ltd.

Recruiting

A Study of Telitacicept in Lupus Nephritis

Lupus Nephritis

China
RemeGen Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome

Primary Sjogren's Syndrome

China
EuBiologics Co.,Ltd

Recruiting

A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older

COVID-19

Congo, The Democratic Republic of the
RemeGen Co., Ltd.

Recruiting

To Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer (Including AEG)

Gastric Cancer

China
RemeGen Co., Ltd.

Recruiting

A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours

Advanced Solid Tumours

China
ICM Co. Ltd.

Not yet recruiting

A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis.

Osteoarthritis, Knee
PegBio Co., Ltd.

Not yet recruiting

Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy

Type 2 Diabetes Mellitus

China
RemeGen Co., Ltd.

Recruiting

A Study of RC118 in Patients With Locally Advanced Unresectable or Metastatic Malignant Solid Tumors

Advanced Solid Tumor

China
Anterogen Co., Ltd.

Recruiting

Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

Dystrophic Epidermolysis Bullosa

United States
Pharmicell Co., Ltd.

Recruiting

Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

Alcoholic Cirrhosis

Korea, Republic of
Microbio Co Ltd

Not yet recruiting

Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Atopic Dermatitis

Staphylococcus Aureus | Atopic Dermatitis
RemeGen Co., Ltd.

Recruiting

A Study of RC48-ADC for the Treatment of HER2-expressing Gynecological Malignancies

Gynecological Malignancy

China
Helixmith Co., Ltd.

Recruiting

A 6-Month Extension Study of VMDN-003-2 to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy (REGAiN-1B)

Diabetic Peripheral Neuropathy

United States
LintonPharm Co.,Ltd.

Recruiting

Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine

Bladder Cancer

China
Pharmicell Co., Ltd.

Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis (Cellgram-LC)

Alcoholic Cirrhosis

Korea, Republic of
TCI Co., Ltd.

Recruiting

Use Babyguard® Breast Milk Probiotics to Verify the Authenticity of the Gut-Breast Axis Hypothesis

Intestinal Bacteria Flora Disturbance

Taiwan
Qurient Co., Ltd.

Recruiting

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor

Solid Tumor | Metastatic Cancer | Advanced Cancer

United States
Anterogen Co., Ltd.

Recruiting

Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.

Diabetic Foot Ulcer

Korea, Republic of
TCI Co., Ltd.

Recruiting

The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults

Overweight | Fatty Liver Disease

Taiwan
TCI Co., Ltd.

Recruiting

The Evaluation of TCI378 and TCI507 Probiotics on Weight-lowering Efficacy in Adults

Weight Loss

Taiwan
TCI Co., Ltd.

Recruiting

The Efficacy Evaluation of Buckwheat Husk Extract on Cardiovascular Disease Risk Factors

Cardiovascular Diseases

Taiwan
RemeGen Co., Ltd.

Recruiting

A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors

Solid Tumor

China
Medipost Co Ltd.

Recruiting

Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial

Bronchopulmonary Dysplasia

Korea, Republic of
RemeGen Co., Ltd.

Recruiting

A Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum Disorders

Neuromyelitis Optica Spectrum Disorders

China
Anterogen Co., Ltd.

Recruiting

A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial

Crohn Disease

Korea, Republic of
ICM Co. Ltd.

Enrolling by invitation

A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo

Osteoarthritis, Knee

Australia
Genoss Co., Ltd.

Completed

Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions

Coronary Artery Disease

Korea, Republic of
TCI Co., Ltd.

Active, not recruiting

Evaluation of the Sleep-relieving Effect of Banana Peel Extract

Impaired Attention

Taiwan
CHABiotech CO., Ltd

Completed

Evaluation of the Safety and Potential Therapeutic Effects of Cordstem-ST in Patients With Cerebral Infarction

Cerebral Infarction

Korea, Republic of
CHABiotech CO., Ltd

Terminated

A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD

Dry Age Related Macular Degeneration

Korea, Republic of
Genoss Co., Ltd.

Active, not recruiting

Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Chinese Patients With Coronary ISR

Coronary Artery Disease

China
Pharmicell Co., Ltd.

Active, not recruiting

Long-term Follow-up of Patients With Chronic Kidney Disease Who Had Administered Cellgram-CKD in PMC-P-12 Study

Renal Insufficiency, Chronic

Korea, Republic of
RemeGen Co., Ltd.

Active, not recruiting

A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases

Breast Neoplasms | Breast Diseases | HER2-positive Breast Cancer | Capecitabine | HER2 Positive Breast Carcinoma | HER2-positive Advanced Breast With Liver Metastases

China
InventisBio Co., Ltd

Completed

Mass Balance Study of [14C] D-1553 in Chinese Healthy Adult Male Subjects

Mass Balance Study

China
InventisBio Co., Ltd

Completed

A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer

Breast Cancer

United States, China
EuBiologics Co.,Ltd

Completed

Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old

Infection, Meningococcal

Korea, Republic of
RemeGen Co., Ltd.

Completed

A Study of RC48-ADC in Subjects With Advanced Breast Cancer

Advanced Breast Cancer

China
RemeGen Co., Ltd.

Completed

A Study of RC48-ADC in Subjects With HER2-negative Locally Advanced or Metastatic Urothelial Cancer

Urothelial Carcinoma

China
RemeGen Co., Ltd.

Completed

A Study of RC48-ADC in Subjects With Advanced Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

China

3

Subscribe